Ftse Mib
33.812,44
0,12%
DAX
18.417,55
0,62%
S&P 500
5.459,10
1,11%
NASDAQ
17.357,88
1,03%
Bitcoin
68.274,54
0,54%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bone Biologics Corporation (BBLG) Bone Biologics Corporation (BBLG) Notizie

BBLG

Bone Biologics (BBLG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BBLG
DataOraFonteTitoloSimboloCompagnia
21/06/202414:35GlobeNewswire Inc.Life Science Virtual Investor Forum Presentations Now Available for Online ViewingNASDAQ:BBLGBone Biologics Corporation
06/03/202422:15Business WireBone Biologics Announces Closing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
05/03/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
04/03/202423:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BBLGBone Biologics Corporation
04/03/202415:15Business WireBone Biologics Announces Pricing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
01/03/202414:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
01/03/202414:00Business WireBone Biologics Reports Progress With NB1 Clinical ProgramNASDAQ:BBLGBone Biologics Corporation
26/02/202422:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
21/02/202423:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BBLGBone Biologics Corporation
15/02/202400:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
30/01/202423:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
19/01/202423:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
17/01/202423:21Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
11/01/202414:00Business WireBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsNASDAQ:BBLGBone Biologics Corporation
10/01/202423:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
10/01/202414:00Business WireBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:BBLGBone Biologics Corporation
05/01/202423:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
18/12/202314:00Business WireBone Biologics Announces 1-for-8 Reverse Stock SplitNASDAQ:BBLGBone Biologics Corporation
29/11/202318:26Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BBLGBone Biologics Corporation
27/11/202312:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BBLGBone Biologics Corporation
20/11/202318:38Business WireBone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BBLGBone Biologics Corporation
20/11/202313:44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BBLGBone Biologics Corporation
20/11/202313:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BBLGBone Biologics Corporation
20/11/202312:50Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BBLGBone Biologics Corporation
16/11/202322:43Business WireBone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BBLGBone Biologics Corporation
14/11/202322:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BBLGBone Biologics Corporation
09/11/202322:51Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BBLGBone Biologics Corporation
26/09/202314:00Business WireBone Biologics Provides Scientific Update on NB1 Bone Graft DeviceNASDAQ:BBLGBone Biologics Corporation
15/09/202322:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BBLGBone Biologics Corporation
03/08/202312:25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BBLGBone Biologics Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BBLG

La tua Cronologia

ASX
MZ1HB
Medallion Trust Series 2...
FX
UZSEUR
UZS vs Euro
ASX
CUL
Cullen Resources
LSE
0F4R
Loulis Mills
FX
MXNTRY
MXN vs TRY
COIN
LMCHGBP
Latam Cash
BOV
JCIN11
Fof Jhsf Capital Instit ...
BIT
F17910
Vontobel Financial Produ...
BTRX
IRISUSDT
NASDAQ
ABFDIXX
Barclays Bank Plc Capped...
NASDAQ
ABHABXX
Barclays Bank Plc Point ...
NASDAQ
ZAFZZX
Baltcap Infrastructure F...
NASDAQ
FCMEXX
Ecommerce Opportunity Po...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network